foxo4-dri senolytic 2023 2024 study

foxo4-dri senolytic 2023 2024 study Peptide Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes FOXO4-DRI regulates endothelial cell senescence

Name: foxo4-dri senolytic 2023 2024 study Peptide Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes FOXO4-DRI regulates endothelial cell senescence
Brand: condeoeiras.edu.pt
SKU: 93567818249
Price: 29.01 USD
Availability: InStock
Rating: 4.0567 (11 reviews)

FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram

SKU: 93567818249 · From condeoeiras.edu.pt

4.1

USD29.01 USD49.01

Pay in 4 interest-free payments of $7.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

BPC-157 - Tissue Repair and Musculoskeletal Research BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice